From the Journal Sentinel
Despite months of additional study and a self-imposed timetable, the U.S. Food and Drug Administration likely will not release its ruling Monday on the safety of bisphenol A
, a chemical used in thousands of household products that has been linked to developmental and behavioral problems.
Sources told the Journal Sentinel the agency instead is likely to ask for more time as its scientists consider hundreds of new studies on the chemical's effects.
Last year, relying on two studies paid for by BPA-makers, the FDA held the chemical was safe for all uses. But the FDA's own science board recommended that the agency had not considered enough of the other studies on the chemical. Earlier this year, the FDA said it would review its findings and set the Nov. 30 deadline.
Advocates for a ban on BPA viewed the prospect of a delay as a good sign, figuring if the FDA plans to maintain its earlier ruling the agency would not need more time.
Additionally, environmentalists were pleased at the recent appointment of Lynn Goldman, a pioneer in research on endocrine-disrupting chemicals and a leading voice for strong environmental health policy, to act as a part-time consultant to the FDA on the chemical.
Advocates of a ban, and packaging company executives who maintain BPA is safe, have anxiously awaited the new FDA ruling.